FORMULATION AND EVALUATION OF IMMEDIATE RELEASE TABLETS OF FLUNARIZINE DI-HYDROCHLORIDE
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2014, Vol 3, Issue 2
Abstract
Immediate release tablets have started gaining popularity and acceptance as a drug delivery system, mainly because they are easy to administer, has quick onset of action, economical and lead to better patient compliance. The aim of the present study was to prepare an immediate release tablet of Flunarizine di-Hydrochloride for the effective treatment of migraine. Tablets were formulated using various concentrations of croscarmellose sodium as superdisintegrant. A total eight formulations were prepared. All formulation were satisfactory for physical appearance including size, shape, thickness and other evaluation factors like weight uniformity, disintegration time, friability, hardness, drug content and in-vitro drug release. The tablet disintegration time was found to be less than 1min for the optimum batch. In vitro drug release was found maximum in F8 formulation which is 97.75±0.43 %. The optimized formulation also showed satisfactory size, shape, thickness and other evaluation factors like weight uniformity (177.77 ± 0.59 mg), disintegration time (37 ± 0.42 sec) , friability (less than 1%), hardness (3.0 kg/m2), drug content (100.21±0.99%).
Authors and Affiliations
Chauhan BS*| Jaipur College of Pharmacy, Jaipur, Rajasthan, India., Jha RK| Jaipur College of Pharmacy, Jaipur, Rajasthan, India., Jaimini M| Jaipur College of Pharmacy, Jaipur, Rajasthan, India., Sharma SK| Jaipur College of Pharmacy, Jaipur, Rajasthan, India.
Keywords
Related Articles
- EP ID EP2425
- DOI -
- Views 437
- Downloads 25
NUTRIGENOMICS: A NEW PARADIGM FOR REVEALING PERIODONTAL INTERRELATIONSHIPS
Improved understanding of the mechanism behind periodontal tissue devastation, the potential protective role of nutrients and the advent of modern genomic measurement tools have led to an increased interest in the associ...
Immunoprecipitation of 11 ZN fingers Domains, CTCF and BORIS to Multifunctional Y-box DNA/RNA-binding factor, YB-1 in Glioma-RGBM
CCCTC binding factor (CTCF) is a unique highly conserved and ubiquitously expressed 11 zinc finger (ZF) transcriptional factor with multiple target site. It is able to bind to various target sequences to perform differen...
STUDY OF SAFETY AND EFFECTIVENESS OF SUBTENON’S ANESTHESIA VERSUS PERIBULBAR ANESTHESIA IN CATARACT SURGERIES.
Aim & Objectives of the study: To compare the safety and effectiveness of subtenon’s anesthesia verusus peribulbar anesthesia in small incision cataract surgeries done at Shri.B.M.Patil medical college hospital Bijapur....
EFFICACY OF ORNIDAZOLE GEL AS AN ADJUNCT TO SCALING AND ROOT PLANING IN CHRONIC PERIODONTITIS PATIENTS: A CLINICAL AND MICROBIOLOGICAL STUDY.
INTRODUCTION: Periodontitis is an inflammatory disease of the supporting tissues of teeth caused by specific group of microorganisms resulting in destruction of periodontal ligament, alveolar bone with pocket formation,...
PHARMACOMETRIC BASED DESIGN AND ANALYSIS BRIDGING THE GAP FOR PEDIATRIC CLINICAL TRIALS
A major test is recognizing, enrolling, and enlisting patients. The accessible pool of kids for target implications is much littler than grown-ups, and moral stipulations essentially restrict the amount of participants.